Vanberra Signal
Free trial

Novai

Curated by Signal

Developer of technology for retinal drug development

Life Sciences Technologynovai.co.uk

Overview

Developer of technology for retinal drug development. The company's DARC technology, a retinal biomarker uses AI- technology for drug development for AMD, retinal, neurological among other therapeutics. Also, developing biologic to control cellular level disease activity for treatment for Multiple Sclerosis, Alzheimer’s Disease, Parkinson’s Disease, Diabetes Mellitus, and Cancer.

Key facts

Founded
2019
Headquarters
London, United Kingdom
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

1 product or service
Sign up to view

Contact

Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • PostEra

    AI based molecular designing software for drug discovery

    Life Sciences TechnologyLondon, United Kingdom

  • Carbometrics

    Developer of glucose monitoring solution for diabetes

    Life Sciences TechnologyBristol, United Kingdom

  • Modius Health

    Device for weight loss

    Life Sciences TechnologyBelfast, United Kingdom

About Novai

What does Novai do?

Developer of technology for retinal drug development.

Where is Novai headquartered?

Novai is headquartered in London, United Kingdom.

When was Novai founded?

Novai was founded in 2019.

Which sector is Novai in?

Novai operates in Life Sciences Technology.

Who are Novai's competitors?

Companies similar to Novai include PostEra, Carbometrics, and Modius Health.